Sign Up to like & get
recommendations!
0
Published in 2020 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-020-0875-8
Abstract: Numerous studies have established bortezomib-based tripleinduction regimens followed by high-dose melphalan chemotherapy with autologous stem cell transplantation (ASCT) as first-line treatment in fit myeloma patients [1–3]. Cyclophosphamide with G-CSF or G-CSF alone are most frequently…
read more here.
Keywords:
cd34 mobilization;
gemcitabine;
vinorelbine;
myeloma patients ... See more keywords